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ABSTRACT
Percutaneous approaches to upper tract urothelial cancers
have been performed in patients unsuitable for radical
nephroureterectomy. We present the case of an 82-year-
old man with significant comorbidities including depen-
dency on a cardiac pacemaker. Without deactivating the
pacemaker, we used bipolar cautery to percutaneously
resect a large upper tract urothelial tumor in the renal
pelvis. Bipolar cautery is a suitable method of percutane-
ous or transurethral resection in patients who are pace-
maker dependent.
Key Words: Electrosurgery, Urothelial carcinoma, Artifi-
cial Pacemaker.
INTRODUCTION
It is well established that the presence of neoplasms in the
upper tract urothelium necessitates the en bloc removal of
the ipsilateral kidney, ureter, and bladder cuff as the
standard of care based on the premise that urothelial
cancers are caused by a field change or defect. However,
due to the morbidity associated with open nephroureter-
ectomies, conservative management may be appropriate
for poor surgical candidates.1 Percutaneous and uretero-
scopic techniques have been utilized in the management
of urothelial tumors with percutaneous access required to
treat larger of upper tract urothelial cancers being used in
suitable candidates.1,2 Various techniques for this ap-
proach have been reported including monopolar electro-
cautery, laser, rollerball, and electrovaporization. The re-
ported recurrence rates have been low, and disease-free
survival is comparable to that in patients treated with
nephroureterectomy.1 The use of monopolar electrosur-
gery however can interfere with cardiac pacemakers re-
sulting in potentially fatal dysrhythmias.
We report the case of an upper tract urothelial carcinoma
in the renal pelvis resected with bipolar cautery through
percutaneous access without deactivation of the cardiac
pacemaker. To our knowledge, the use of bipolar cautery
has not been described in this setting.
METHODS
An 82-year-old man who was a lifelong nonsmoker pre-
sented with a history of intermittent gross hematuria. His
medical comorbidities included non-insulin-dependent
diabetes, hypertension, hypercholesterolemia, hypothy-
roidism, chronic renal insufficiency (creatinine 2.4 mg/
dL), multiple transient ischemic attacks, stroke, sleep ap-
nea, peripheral vascular disease resulting in a below-knee
amputation, colon resection for diverticulitis, and a VDD
pacemaker (Model # 640, Vitatron, Minneapolis, MN) for
bradycardia. His medications included aspirin, ramipril,
hydrochlorothiazide, L-thyroxine and rosuvastatin. His
preoperative cardiac risk was Goldman Class II-III, and he
was at high risk of developing a deep venous thrombosis.
Postoperative respiratory depression was a concern due
to his sleep apnea.
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CASE REPORTInitial cystoscopic examination revealed no bladder tu-
mors. The retrograde pyelogram on the right side was
normal, but the left retrograde pyelogram demonstrated
moderate hydronephrosis in a bifid collecting system and
a 2-cm filling defect in the renal pelvis with renal malro-
tation (Figure 1). Urine cytology was positive for urothe-
lial carcinoma. A CT scan of the abdomen and pelvis
revealed a tumor limited to the left renal collecting system
with no evidence of metastases. Further, a metastatic
workup was negative.
Based on a background of renal insufficiency, the options
were discussed with the patient and a tumor ablation with
the Holmium:YAG laser and flexible ureteroscopy was
carried out. The ureteroscopic procedure was ineffective
in completely ablating the tumor at its stalk because the
ureteroscope could not fully access the tumor due to the
capacious renal pelvis and renal malrotation. This patient
was dependent on his VDD pacemaker, thus making
monopolar cautery potentially hazardous. Therefore, a
percutaneous resection using a bipolar resectoscope was
planned under a second general anesthetic without deac-
tivating the pacemaker.
RESULTS
With the patient under general anesthesia, percutaneous
access to the kidney was obtained, the tract was dilated to
30 F, and an Amplatz sheath was inserted. A resectoscope
using bipolar cautery (VISTA, ACMI Corporation, South-
borough, MA) was used to resect the tumor (settings: cut,
6; coagulation, 6) through the Amplatz sheath. The oper-
ation lasted 30 minutes without any evidence of dysrhyth-
mias or interference with the pacemaker. A 22 F nephros-
tomy tube was left indwelling until postoperative day 1
when it was removed, and the patient was discharged
home without any complications. The patient used a con-
tinuous positive airway pressure (CPAP) machine postop-
eratively that helped prevent any postoperative respira-
tory complications. There were no cardiac or
thromboembolic complications. The patient was seen in
follow-up at 3 months with an intravenous pyelogram
(IVP) that was free of any filling defects and negative
cytology. Serum creatinine increased only slightly from 2.4
mg/dL (preoperatively) to 2.6 mg/dL, postoperatively. At
8 months, a retrograde pyelogram revealed a recurrence
of his upper tract tumor that was too large for uretero-
scopic management, and percutaneous bipolar resection
was once again undertaken. The patient declined upper
tract bacille Calmette-Gue ´rin therapy and laparoscopic
nephroureterectomy due to his declining health including
a recent cerebral vascular accident. At 6 months, the pa-
tient remains free of recurrent or metastatic disease with
stable renal function (2.5 mg/dL).
DISCUSSION
Bipolar electrocautery was introduced over 20 years ago
as an energy source for endourologic procedures.3 The
potential benefits of bipolar energy include the use of
isotonic normal saline irrigation and improved hemosta-
sis.3 Importantly, it can also be used on patients with
permanent cardiac pacemakers and has been described in
a case involving transurethral resection of a bladder tumor
in a similar pacemaker-dependent patient.4
Electrocautery-induced cardiac pacemaker failure or mal-
function has been well described.5,6 Since the invention of
cardiac pacemakers nearly 50 years ago, electromagnetic
interference has been a concern for patients who wear
them. Over the years, despite improved technology, per-
manent cardiac pacemakers remain susceptible to this
electromagnetic interference, including electrocautery,
during surgical procedures.5 Traditionally, the use of mo-
nopolar electrosurgery is avoided in patients with cardiac
pacemakers because the monopolar current passes from
the instrument tip through the patient’s body towards the
ground plate and may adversely affect the pacemaker,
resulting in potentially fatal dysrhythmias. Bipolar electro-
Figure 1. Retrograde pyelogram displaying a renal filling defect
in a bifid renal collecting system with a malrotated kidney.
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trocautery units and pacemaker electrodes.5
Bipolar electrosurgery has also been shown to reduce the
depth of thermal damage at the site of surgery. In an ex
vivo porcine kidney model, Wendt-Nordahl et al7 com-
pared the effects of the Vista bipolar system to monopolar
cautery. The depth of thermal damage was significantly
deeper at 300 m measured with the monopolar resecto-
scope but only reached 160 m with the bipolar device
even at the highest output level (level 8). The lower tissue
temperature may be beneficial during resection of upper
tract renal tumors. Excessive heat may cause problems
with the urothelium of the renal collecting system or
penetrate deeply into parenchyma resulting in arterio-
venous fistulae.
Radical nephroureterectomy is the gold standard in the
treatment of upper tract urothelial malignancies. How-
ever, in patients with significant medical comorbidities
who are not candidates for radical surgery, bipolar resec-
tion through a percutaneous access is an alternative.
Given the patient’s cardiac status, a bipolar resectoscope
was used not only to perform tumor resection but also to
minimize the risk of electrical interference with the pace-
maker. Both ureteroscopy and percutaneous laser abla-
tion would have been tedious due to tumor size and
location. Disease recurrence occurred due to multifocality
and not due to failure of the initial bipolar procedure. It
can be argued that the patient underwent 2 endoscopic
procedures while under general anesthesia, whereas a
laparoscopic nephroureterectomy would have offered
treatment in a single procedure; however, the single pro-
cedure would have required more surgical time in one
sitting and is much more invasive than 2 short endoscopic
procedures. The mortality and morbidity risk would be
higher with a nephroureterectomy than 2 shorter endo-
scopic procedures.
While the use of the bipolar electrocautery may be advan-
tageous in the percutaneous resection of upper tract
urothelial tumors, potential drawbacks of this technique
include limited utility depending on tumor location and
access, and dessication of the tissue creating more artifacts
for pathological examination. It is advisable to perform a
cold biopsy of the tumor for both pathology and margin
status before using the bipolar electrocautery. More im-
portantly, this approach is not a replacement for
nephroureterectomy but may be an option for nonsurgical
candidates or patients who may benefit from nephron-
sparing procedures. It may be a palliative procedure in
some cases and potentially therapeutic in others. As illus-
trated in this case, the use of bipolar electrocautery cir-
cumvents the potential risks of using electrocautery in
patients with cardiac pacemakers.
CONCLUSION
Bipolar electrocautery is a safe and feasible resection
modality in percutaneously approached upper tract
urothelial neoplasms in patients with cardiac pacemakers.
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